全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

亚肺叶切除联合125I粒子植入治疗早期肺癌有效性的Meta分析与系统评价
Meta-analysis and system evaluation of 125I implantation in the treatment of early lung cancer

DOI: 10.6040/j.issn.1671-7554.0.2017.039

Keywords: 125I粒子植入,早期非小细胞肺癌,亚肺叶切除,有效性,系统评价,Meta分析,
125I implantation
,Early non-small cell lung cancer,Efficacy,System evaluation,Sublobar resection,Meta-analysis

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]  Manning M, Burney D, Bryant C. Efficacy of sublobar resection with <sup>125</sup>I brachymesh at two years for early stage non-small cell lung cancer(NSCLC)[J]. Brachytherapy, 2011, 10: S74-S75.
[2]  Manning MA, Mohamed M, Burney DP. Sublobar resection with <sup>125</sup>I brachytherapy for early-stage non-small cell lung cancer(NSCLC)using prefabricated mesh[C]. J Clinic Oncol, 2009, 27(15S): 7586.
[3]  Lee W, Daly BDT, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local control with implantation of <sup>125</sup>I brachytherapy seeds[J]. AnnThorac Surg, 2003, 75(1): 237-242.
[4]  Voynov G, Heron DE, Lin CJ, et al. Intraoperative <sup>125</sup>I Vicryl mesh brachytherapy after sublobar resection for high-risk stage Ⅰ nonsmall cell lung cancer[J]. Brachytherapy, 2005, 4(4): 278-285.
[5]  Khuntia D, Weigel TL, Orcutt KP, et al. Intraoperative <sup>125</sup>I mesh brachytherapy after wedge resection for medically high risk stage Ⅰ non-small cell lung cancer: the university of wisconsin experience[J]. Brachytherapy, 2010, 9: S84-S85.
[6]  柯明耀, 雍雅智, 罗炳清, 等. 经皮植入<sup>125</sup>I放射性粒子治疗老年Ⅰ期周围型非小细胞肺癌探讨[J]. 中华放射肿瘤学杂志, 2011, 20(5): 394-396. KE Mingyao, YONG Yazhi, LUO Bingqing, et al. Study of percutaneous <sup>125</sup>I seeds implantation guided by CT in elderly patients of stage Ⅰ peripheral non-small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2011, 20(5): 394-396.
[7]  赫捷, 赵平, 陈万青. 2012中国肿瘤登记年报[M]. 北京: 军事医学科学出版社, 2012: 13-16.
[8]  Beckles MA, Spiro SG, Colice GL, et al. The physiologic evaluation of patients with lung cancer being considered for resectional surgery[J]. Chest, 2003, 123(1 Suppl): 105S-114S.
[9]  Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer[J]. Ann Thorac Surg, 1995, 60(3): 615-623.
[10]  Madsen JS, Wallstedt B, Brandt CJ, et al. Questions as evident key to knowledge: teaching medical students evidence-based medicine[J]. Ugeskr Laeger, 2001, 163(26):3609-3613.
[11]  Isaac M, Kaminsky A, Onufrey VG, et al. Intraoperative <sup>125</sup>I brachytherapy mesh after sublobar resection in early stage high risk non small cell lung cancer[J]. Brachytherapy, 2011, 10: S23-S24.
[12]  Evans AJ, Connery C, Bhora F, et al. Sublobar resection and robotic interstitial brachytherapy for early-stage non-small cell lung cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 84(3): S558.
[13]  Colonias A, Betler J, Trombetta M, et al. Mature follow-up for high-risk stage Ⅰ non–small-cell lung carcinoma treated with sublobar resection and intraoperative Iodine-125 brachytherapy[J]. Int J Radiat Oncol Biol Phys, 2011, 79(1): 105-109.
[14]  Chen A, Galloway M, Landreneau R, et al. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma[J]. Int J Radiat Oncol Biol Phys, 1999, 44(5): 1057-1063.
[15]  Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
[16]  Sco WJ, Howington J, Feigenberg S, et al. Treatment of non-small cell lung cancer stage I and stage II. ACCP evidencebased clinical practice guidelines[J]. Chest, 2007, 132(Suppl 3): 234-242.
[17]  Fernando HC, Landreneau RJ, Mandrekar SJ, et al. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032(Alliance), a phase Ⅲ randomized trial for high-risk operable non-small-cell lung cancer[J]. J Clin Oncol, 2014, 32(23): 2456-2462.
[18]  曾庆武, 刘俊. 肺楔形切除联合<sup>125</sup>I粒子植入治疗高危Ⅰ期非小细胞肺癌的临床研究[J]. 中国医药指南, 2010, 8(20): 99-101. ZENG Qingwu, LIU Jun. Clinical study of pulmonary wedge resection combined with <sup>125</sup>I seed implantation in the treatment of stage Ⅰ non-small cell lung cancer with high risk[J]. Guide of China Medicine, 2010, 8(20): 99-101.
[19]  Fernando HC, Santos RS, Benfield JR, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer[J]. J Thorac Cardiovasc Surgery, 2005, 129(2): 261-267.
[20]  Bigdeli G, Adurty R, Kaplan P, et al. Radiographic changes after wedge resection and intraoperative <sup>125</sup>I brachytherapy in stage Ⅰ lung cancer[J]. Chest, 2009, 136(4): 140S-c-141S.
[21]  Okada M, Koike T, Higashiyama M, et al. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study[J]. J Thorac Cardiovasc Surg, 2006, 132(4): 769-775.
[22]  Khullar OV, Liu Y, Gillespie T, et al. Survival after sublobar resection versus lobectomy for clinical stage IA lung cancer: an analysis from the national cancer data base[J]. J Thorac Oncol, 2015, 10(11): 1625-1633.
[23]  Speicher PJ, Gu L, Gulack BC, et al. Sublobar resection for clinical stage IA non-small-cell lung cancer in the United States[J]. Clin Lung Cancer, 2016, 17(1): 47-55.
[24]  Taioli E, Yip R, Olkin I, et al. Survival after sublobar resection for earlystage lung cancer: methodological obstacles in comparing the efficacy to lobectomy[J]. J Thorac Oncol, 2016, 11(3): 400-406.
[25]  Birdas TJ, Koehler RPM, Colonias A, et al. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer[J]. The Annals of thoracic surgery, 2006, 81(2): 434-439.
[26]  杨景魁, 吕金爽, 阎卫亮, 等. 放射性粒子植入治疗不能手术的早期非小细胞肺癌疗效分析[J]. 中国肿瘤临床, 2014, 41(17): 1111-1114. YANG Jingkui, Lü Jinshuang, YAN Weiliang, et al. Analysis of curative effect of implantation of radioactive seeds on inoperable early-stage non-small cell lung cancer[J]. Chinese Journal of Clinical Oncology, 2014, 41(17): 1111-1114.
[27]  杨景魁, 霍小东, 闫卫亮, 等. CT引导下经皮穿刺<sup>125</sup>I粒子植入治疗非手术的早期非小细胞肺癌疗效分析[J]. 中华老年医学杂志, 2014, 33(7): 757-759. YANG Jingkui, HUO Xiaodong, YAN Weiliang, et al. Effect of CT-guided <sup>125</sup>I seeds implant brachytherapy on early non-small cell lung cancer[J]. Chinese Journal of Geriatrics, 2014, 33(7): 757-759.
[28]  李玉亮, 王永正, 张福君. CT引导下经皮穿刺植入<sup>125</sup>I粒子治疗老年中心型肺癌近期疗效分析[J]. 中华肿瘤防治杂志, 2007, 14(23): 1818-1820. LI Yuliang, WANG Yongzheng, ZHANG Fujun. Effect of curing central bronchogenic cancer by percutaneous interstitial <sup>125</sup>I particle implanting under CT guided in old patients[J]. Chinese Journal of Cancer Prevention and Treatment, 2007, 14(23): 1818-1820.
[29]  焦德超, 张福君, 陆郦工, 等. <sup>125</sup>I粒子组织间植入治疗肺恶性肿瘤[J]. 介入放射学杂志, 2008, 17(3): 190-193. JIAO Dechao, ZHANG Fujun, LU Ligong, et al. CT guided radioactive <sup>125</sup>I seed implantation in treating lung malignant tumors[J]. Journal of Interventional Radiology, 2008, 17(3): 190-193.
[30]  Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and 125 iodine brachytherapy after sublobar resection in high-risk patients with stage I non-small-cell lung cancer[J]. Surgery, 2003, 134(4): 691-697.
[31]  Kotinsley KA, Betler J, Kotinsley B, et al. Outcome analysis of sublobar resection and intraoperative <sup>125</sup>I brachytherapy vs. stereotactic body radiotherapy in stage I non-small cell lung carcinoma[J]. Int J Rad Oncol Biol Phys, 2011, 81(2): S162-S163.
[32]  Hilaris BS, Nori D, Martini N. Intraoperative radiotherapy in stage Ⅰ and Ⅱ lung cancer[C]. Semin Surg Oncol, 1987, 3(1): 22-32.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133